Drugplain

Syzygium jambolanum 30 [hp_C]/30[hp_C]

SYZYGIUM CUMINI SEED · PELLET · Boiron

No Recall History
Plain English

Syzygium jambolanum is a pellet containing syzygium cumini seed at 30 [hp_C]/30[hp_C], taken oral. Manufactured by Boiron.

Key Facts

Brand Name
Syzygium jambolanum
Generic Name
SYZYGIUM CUMINI SEED
NDC Code (Product)
0220-7842
Manufacturer
Boiron
Strength
30 [hp_C]/30[hp_C]
Dosage Form
PELLET
Route
ORAL
Marketing Status
Marketing Start
03/03/1983

Recall History

No Recall History

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

INDICATIONS Condition listed above or as directed by the physician

Dosage & Administration

DOSAGE Adults- Take 4 or 6 Pellets by mouth, three times daily or as suggested by physician. Children 2 years and older- take 1/2 the adult dose.

Warnings

WARNINGS This product is to be used for self-limiting conditions If symptoms do not improve in 4 days, or worsen, discontinue use and seek assistance of health professional As with any drug, if you are preganant, or nursing a baby, seek professional advice before taking this product Keep this and all medication out of reach of children Do not use if capseal is broken or missing. Close the cap tightly after use.

Frequently Asked Questions

What is Syzygium jambolanum used for?

Syzygium jambolanum contains SYZYGIUM CUMINI SEED. It is a pellet taken oral. Consult your doctor for specific uses.

Is Syzygium jambolanum a controlled substance?

Syzygium jambolanum is not classified as a controlled substance by the DEA.

What is the generic name for Syzygium jambolanum?

The generic name for Syzygium jambolanum is SYZYGIUM CUMINI SEED. There are no other listed brand versions of SYZYGIUM CUMINI SEED.

What is the NDC code for Syzygium jambolanum 30 [hp_C]/30[hp_C]?

The NDC (National Drug Code) for Syzygium jambolanum 30 [hp_C]/30[hp_C] is 0220-7842, listed by Boiron.

Product NDC

0220-7842

Package NDC

0220-7842-41

Other Syzygium jambolanum Dosages

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)